Hydroxyapatite-coated femoral components in total knee arthroplasty: medium term results.
Thirty-six consecutive total knee arthroplasties with hydroxyapatite (HA)-coated femoral components were prospectively followed up according to a standardised protocol for a mean period of 10 years (range, 7-11 years). Clinical and radiologic examination was performed at each follow-up evaluation. One patient (1 knee) was lost to follow up at 7 years, and 4 other patients (6 knees) died. Radiographs were studied for signs of loosening and presence of lucencies. Survival analysis was performed using a life table with revision as the criterion for failure. Two knees (1 patient) were revised because of aseptic loosening. The tibial component of one other knee was revised because of osteolysis in the medial tibial condyle. In the remaining knees, no radiologic evidence of loosening was seen. The survival of the femoral component at a mean follow-up time of 7 years, when 31.5 knees were at risk, was 94% with revision for femoral aseptic loosening as the end point. At 10 years, when 24 knees were at risk, the survival remained 94%.
Murty
Aradhyula Narasimha
AN
Bone and Joint Research Unit, The Royal London Hospital, Whitechapel, London, United Kingdom.
Scott
G
G
Freeman
M A R
MA
D000203:Activities of Daily Living; D000368:Aged; D019645:Arthroplasty, Replacement, Knee / Q000295:instrumentation*; D001672:Biocompatible Materials / Q000627:therapeutic use*; D017886:Durapatite / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007592:Joint Diseases / Q000601:surgery; D007720:Knee Prosthesis; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012086:Reoperation; D016896:Treatment Outcome
D001672:Biocompatible Materials; D017886:Durapatite